Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sarah Kandoussi"'
Autor:
Oumayma Naji, Amina Ghouzlani, Soumaya Rafii, Rizwan ullah Sadiqi, Abdou-samad Kone, Zakia Harmak, Khalil Choukri, Sarah Kandoussi, Mehdi Karkouri, Abdallah Badou
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The interplay between immune cells and malignant cells represents an essential chapter in the eradication of breast cancer. This widely distributed and diverse form of cancer represents a major threat to women worldwide. The incidence of breast cance
Externí odkaz:
https://doaj.org/article/66f75f9617364335a32da3d2aa83300f
Autor:
Soumaya Rafii, Sarah Kandoussi, Amina Ghouzlani, Oumayma Naji, Konala Priyanka Reddy, Rizwan Ullah Sadiqi, Abdallah Badou
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Gliomas are considered one of the most malignant cancers in the body. Despite current therapies, including surgery, chemotherapy, and radiotherapy, these tumors usually recur with more aggressive and resistant phenotypes. Indeed, the survival followi
Externí odkaz:
https://doaj.org/article/46d0cc04bd174c03963c79ead3a61bca
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chimeric antigen receptor (CAR) T-cells represent a new genetically engineered cell-based immunotherapy tool against cancer. The use of CAR T-cells has revolutionized the therapeutic approach for hematological malignancies. Unfortunately, there is a
Externí odkaz:
https://doaj.org/article/8d93da66ad294b82b96f4d64124d863f
Autor:
Amina Ghouzlani, Sarah Kandoussi, Mariam Tall, Konala Priyanka Reddy, Soumaya Rafii, Abdallah Badou
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Gliomas are the most common primary brain tumors in adults. Despite the fact that they are relatively rare, they cause significant morbidity and mortality. High-grade gliomas or glioblastomas are rapidly progressing tumors with a very poor prognosis.
Externí odkaz:
https://doaj.org/article/0fd383c7374e4f5cba1a38de287014f4
Autor:
Soumaya Rafii, Amina Ghouzlani, Oumayma Naji, Saadia Ait Ssi, Sarah Kandoussi, Abdelhakim Lakhdar, Abdallah Badou
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 7; Pages: 6688
Gliomas are considered one of the most malignant tumors in the body. The immune system has the ability to control the initiation and development of tumors, including gliomas. Thus, immune cells find themselves controlled by various molecular pathways
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b256bff000dd2fa350f9400cd5b10b2
Publikováno v:
Journal of Bioinformatics and Systems Biology.
Tumor cells can reverse the immune system's control through secretion or surface expression of several molecules such as immune checkpoint inhibitors. Blocking these immune checkpoint molecules could reactivate the immune system against cancer cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d433cf196873242fb6955c6285956a4
https://doi.org/10.26502/jbsb.5107025
https://doi.org/10.26502/jbsb.5107025
Publikováno v:
Archives of Clinical and Biomedical Research.
Gliomas are considered the most malignant cancers of the body. Despite the advances in cancer therapy, this type of tumor continues to progress and be more aggressive. In human gliomas, anti-tumor T cell responses are inhibited through induction of l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::277207b2c5ce0fa7d6534d63bbaf4265
https://doi.org/10.26502/acbr.50170134
https://doi.org/10.26502/acbr.50170134